Drugs for Urinary Frequency and Incontinence
- Drugs for Urinary Frequency and Incontinence
- Accession Number
- ATC Classification
Drug Drug Description Trospium An antimuscarinic agent used to treat the symptoms of overactive bladder (OAB). Darifenacin An M3 muscarinic receptor blocker used to treat urinary incontinence. Tolterodine A muscarinic receptor antagonist used to treat overactive bladder with urinary incontinence, urgency, and frequency. Oxybutynin An antimuscarinic agent that reduces detrusor muscle activity, relaxing the bladder and preventing the urge to void. Flavoxate A muscarinic antagonist and spasmolytic used for the symptomatic relief of conditions associated with lack of muscle control in the bladder, such as dysuria, urgency, and nocturia. Fesoterodine An antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Mirabegron A beta-3 adrenergic agonist used to treat overactive bladder and neurogenic detrusor overactivity. Propiverine An antimuscarinic agent used to treat urinary incontinence or increased urinary frequency or urgency. Meladrazine Not Annotated Emepronium Not Annotated Terodiline Not Annotated Solifenacin A muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder. Desfesoterodine An antimuscarinic agent indicated in the symptomatic treatment of urinary frequency or incontinence. Vibegron A beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults. Solabegron Investigated for use/treatment in diabetes mellitus type 2, irritable bowel syndrome (IBS), and urinary incontinence. Ritobegron Ritobegron is under investigation in clinical trial NCT02256735 (Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin...
- Drugs & Drug Targets